--- title: Ophthalmology CDMOs path: /indications/ophthalmology companies_count: 11 --- # Ophthalmology CDMOs 11 published CDMOs match Ophthalmology. Locations in this set include United States, United Kingdom, China, India, Australia, and Brazil. Capabilities that show up most often in this set: Formulation Development, Process Development, Stability Testing & Storage, CMC Analytical Development, and Sterile Fill-Finish & Aseptic Manufacturing. ## Matching companies - [Akums Drugs and Pharmaceuticals Ltd.](/companies/akums) - India's largest CDMO with 15+ state-of-the-art facilities and 30% domestic market share, manufacturing 4,100+ formulations across tablets, capsules, injectables, APIs, and specialty dosage forms under WHO-GMP, USFDA, EU-GMP, and TGA compliance. - [Altasciences](/companies/altasciences) - Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities. - [Amneal Pharmaceuticals](/companies/amneal-pharmaceutical) - U.S.-based biopharmaceutical company offering oral solid dosage, injectables, and API manufacturing with FDA-approved facilities across the U.S. and India, including advanced capabilities in lyophilization, aseptic processing, and oncology formulations. - [Forge Biologics](/companies/forgebiologics) - Dedicated AAV gene therapy CDMO with a 200,000+ sq. ft. cGMP facility featuring 20 suites and bioreactors up to 5,000L, supporting 60+ clients across 35+ indications with high-yield manufacturing and seamless regulatory compliance. - [HitGen Inc.](/companies/hitgen) - HitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally. - [IDT Australia](/companies/idtaus-com) - IDT Australia is a cGMP CDMO delivering end-to-end pharmaceutical development and manufacturing services from active pharmaceutical ingredients to finished dosage forms, with expertise in small molecule APIs, specialty orals, advanced therapies, and integrated regulatory support. - [Medpharm](/companies/medpharm) - Specialized CDMO for topical, transdermal, and transepithelial drug products offering formulation development, analytical testing, process scale-up, and GMP manufacturing from early development through commercialization. - [Mytos Inc.](/companies/mytos) - Mytos is an automated CDMO for regenerative medicines, using its iDEM platform to produce stem-cell derived therapies. The company says its automation lets clients scale in months rather than years at lower cost per batch. - [Pharmaron](/companies/pharmaron) - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK. - [Syngene International](/companies/syngeneintl) - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S. - [Unither Pharmaceuticals](/companies/unither-pharma) - Global CDMO specializing in sterile and non-sterile liquid manufacturing, including Blow-Fill-Seal (BFS) single-dose technology with over 5 billion annual capacity, plus formulation development, analytical services, and ophthalmic expertise across six production sites.